Andrew S. Eibling, CSAP
VP, Business Development and Alliance Management
Enable Injections, LLC
Andy Eibling is a 30-year veteran of the pharmaceutical industry and an accomplished Alliance Management and Business Development leader with experience in technology, development, commercialization and supplier relationships. Andy joined Enable Injections in 2018 as Vice President of Business Development and Alliance Management, responsible for establishing and maintaining strategic alliances with biopharma partners leveraging the novel wearable drug delivery system developed by Enable.
He was formerly Vice President of Enterprise Alliance Management at Covance, Inc., the drug development division of LabCorp. Prior to joining Covance, Andy spent over 24 years at Eli Lilly and Company, most recently implementing Lilly’s partnering strategy with roles in Business Development. As a founding member of Lilly’s pioneering Office of Alliance Management, he managed a variety of partnerships.
Andy is a member of the Association of Strategic Alliance Professionals, and a Certified Strategic Alliance Professional. He has spoken at numerous conferences and workshops, and his work on “Unique Aspects of Alliance Projects” was published in Pharmaceutical and Biomedical Project Management in a Changing Global Environment, Wiley, 2010. Andy earned a Bachelor of Science in Mechanical Engineering from Purdue University and a Master of Business Administration from Indiana University.